00000nam 2200000zi 4500 9.910380 CaOODSP 20220913092743 m o d f cr mn||||||||| 220420e202205 onca o f000 0 eng d 9780660431765 CaOODSP eng rda CaOODSP n-cn--- H164-332/2022E-PDF Guidance to market authorization holders on issuing health product risk communications. Ottawa, ON : Health Canada = Santé Canada, May 2022. ©2022 1 online resource (iii, 17 pages) : illustration text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Orientation à l'intention des détenteur d'une autorisation de mise sur le marché concernant la diffusion des communications des risques liés aux produits de santé. "Pub.: 220059." Issued also in HTML format. "The purpose of this document is to assist market authorization holders (MAHs) develop and disseminate health product risk communications (HPRCs). The guidance provided in this document is limited to HPRCs. An HPRC is a specific type of risk communication generated using the Health Canada-developed HPRC template and standardized process. HPRCs are designed to clearly and effectively communicate information to health care professionals about new health-related risks associated with marketed health products such as: drugs, medical devices, and natural health products. The guidelines and procedures described in this document assume that a decision to issue an HPRC has already been made. This document doesn't describe the criteria used to determine whether an HPRC is the ideal risk communication tool to address a particular risk"--Overview, page 1. Health products Government policy Canada. Medical supplies Government policy Canada. Health risk communication Government policy Canada. Canada. Health Canada, issuing body. Orientation à l'intention des détenteur d'une autorisation de mise sur le marché concernant la diffusion des communications des risques liés aux produits de santé. (CaOODSP)9.910381 PDF 1.30 MB https://publications.gc.ca/collections/collection_2022/sc-hc/H164-332-2022-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/medeffect-canada/guidance-market-authorization-holders-on-issuing-health-product-risk-communications.html 220059